BD (NYSE: BDX) filed a patent infringement lawsuit against Baxter (NYSE: BAX) on May 12, 2025, in the U.S. District Court for Delaware. The complaint targets Baxter’s Novum IQ infusion system, alleging unauthorized manufacture, use, and sale.
The dispute involves six patents focused on infusion pump technologies designed to improve interoperability, integrate with electronic medical records, simplify workflows, reduce programming steps, minimize errors, and ensure precise therapeutic delivery. BD’s CareFusion subsidiary offers the Alaris infusion platform, which the patents underpin.
Follow MEDWIRE.AI for medical device legal updates.
